Lv4
560 积分 2024-02-12 加入
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
1个月前
已完结
Efgartigimod for Fetal Acetylcholine Receptor Antibody–Related Disorder
2个月前
已完结
Efgartigimod versus standard of care in new-Onset AChR subtype generalized myasthenia gravis: A prospective cohort study
2个月前
已完结
Efgartigimod versus standard of care in new-Onset AChR subtype generalized myasthenia gravis: A prospective cohort study
6个月前
已完结
Perioperative Safety and Efficacy of Efgartigimod for Thymoma-Associated Myasthenia Gravis: A Prospective, Multicenter, Phase II Clinical Trial
6个月前
已完结
A comprehensive review of the treatment options in myasthenia gravis
6个月前
已完结
Structure and function of the neuromuscular junction in health and myasthenia gravis
6个月前
已完结
In vivo magnetic resonance imaging at 11.7 Tesla visualized the effects of neonatal transection of infraorbital nerve upon primary and secondary trigeminal pathways in rats
8个月前
已完结
Cheiro-Oral-Pedal Syndrome
8个月前
已完结
Single‐cell atlas reveals heterogeneous response to FcRn blockade in anti‐AChR antibody‐positive generalised myasthenia gravis
8个月前
已完结
皖公网安备34019202002308
